Log on / register
Feedback | Support | My details

Pre-publication history

Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study

A Traboulsee email, A AL-Sabbagh email, R Bennett email, P Chang email and DKB Li email for the EVIDENCE Study Group and the UBC MS/MRI Research Group

BMC Neurology 2008, 8:11doi:10.1186/1471-2377-8-11

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript10 Aug 2007
Reviewer's Reportmark Freedman05 Nov 2007
Reviewer's ReportRobert Fox05 Nov 2007
Reviewer's ReportCarlo Pozzilli15 Nov 2007
Resubmission - Version 2Manuscript12 Dec 2007
Reviewer's ReportRobert Fox03 Jan 2008
Reviewer's ReportCarlo Pozzilli04 Jan 2008
Resubmission - Version 3ManuscriptAuthors' comments20 Feb 2008
Resubmission - Version 4ManuscriptAuthors' comments11 Apr 2008
Resubmission - Version 5Manuscript17 Apr 2008
Resubmission - Version 6Manuscript18 Apr 2008
Accepted21 Apr 2008
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated